Colin G. Buss

932 total citations
7 papers, 638 citations indexed

About

Colin G. Buss is a scholar working on Molecular Biology, Oncology and Critical Care and Intensive Care Medicine. According to data from OpenAlex, Colin G. Buss has authored 7 papers receiving a total of 638 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 2 papers in Oncology and 1 paper in Critical Care and Intensive Care Medicine. Recurrent topics in Colin G. Buss's work include Immune Cell Function and Interaction (1 paper), RNA modifications and cancer (1 paper) and Advanced Biosensing Techniques and Applications (1 paper). Colin G. Buss is often cited by papers focused on Immune Cell Function and Interaction (1 paper), RNA modifications and cancer (1 paper) and Advanced Biosensing Techniques and Applications (1 paper). Colin G. Buss collaborates with scholars based in United States and Germany. Colin G. Buss's co-authors include Sohail F. Tavazoie, Nora Pencheva, Klaus J. Busam, Marija Drobnjak, Doowon Huh, Hien Tran, Sangeeta N. Bhatia, Taha Merghoub, Jessica M. Posada and Hani Goodarzi and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Colin G. Buss

7 papers receiving 631 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Colin G. Buss United States 6 411 286 150 131 91 7 638
Magali Castells France 9 279 0.7× 203 0.7× 254 1.7× 223 1.7× 71 0.8× 9 723
Chunhui Zhou China 10 294 0.7× 176 0.6× 158 1.1× 121 0.9× 55 0.6× 29 564
Beate Alinger Austria 19 490 1.2× 152 0.5× 192 1.3× 75 0.6× 76 0.8× 23 734
Shovik Bandyopadhyay United States 10 300 0.7× 221 0.8× 174 1.2× 88 0.7× 104 1.1× 17 589
Nina Raulf United Kingdom 9 482 1.2× 250 0.9× 200 1.3× 98 0.7× 34 0.4× 13 696
Jason J. Kwon United States 10 375 0.9× 279 1.0× 185 1.2× 75 0.6× 71 0.8× 18 605
Saswati Karmakar United States 12 467 1.1× 165 0.6× 301 2.0× 127 1.0× 55 0.6× 20 692
Martin Nurmik Luxembourg 5 411 1.0× 335 1.2× 358 2.4× 125 1.0× 58 0.6× 7 788
Boyao Yu China 7 314 0.8× 224 0.8× 230 1.5× 165 1.3× 32 0.4× 10 585
Elena Vinokour United States 9 456 1.1× 309 1.1× 90 0.6× 114 0.9× 21 0.2× 11 624

Countries citing papers authored by Colin G. Buss

Since Specialization
Citations

This map shows the geographic impact of Colin G. Buss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Colin G. Buss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Colin G. Buss more than expected).

Fields of papers citing papers by Colin G. Buss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Colin G. Buss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Colin G. Buss. The network helps show where Colin G. Buss may publish in the future.

Co-authorship network of co-authors of Colin G. Buss

This figure shows the co-authorship network connecting the top 25 collaborators of Colin G. Buss. A scholar is included among the top collaborators of Colin G. Buss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Colin G. Buss. Colin G. Buss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Buss, Colin G. & Sangeeta N. Bhatia. (2020). Nanoparticle delivery of immunostimulatory oligonucleotides enhances response to checkpoint inhibitor therapeutics. Proceedings of the National Academy of Sciences. 117(24). 13428–13436. 57 indexed citations
2.
Buss, Colin G., Jaideep S. Dudani, Reid Akana, Heather E. Fleming, & Sangeeta N. Bhatia. (2018). Protease activity sensors noninvasively classify bacterial infections and antibiotic responses. EBioMedicine. 38. 248–256. 16 indexed citations
3.
Dudani, Jaideep S., Colin G. Buss, Reid Akana, Gabriel A. Kwong, & Sangeeta N. Bhatia. (2016). Sustained‐Release Synthetic Biomarkers for Monitoring Thrombosis and Inflammation Using Point‐of‐Care Compatible Readouts. Advanced Functional Materials. 26(17). 2919–2928. 31 indexed citations
4.
Goodarzi, Hani, Steven Zhang, Colin G. Buss, et al.. (2014). Metastasis-suppressor transcript destabilization through TARBP2 binding of mRNA hairpins. Nature. 513(7517). 256–260. 73 indexed citations
5.
Pencheva, Nora, Colin G. Buss, Jessica M. Posada, Taha Merghoub, & Sohail F. Tavazoie. (2014). Broad-Spectrum Therapeutic Suppression of Metastatic Melanoma through Nuclear Hormone Receptor Activation. Cell. 156(5). 986–1001. 132 indexed citations
6.
Pencheva, Nora, Hien Tran, Colin G. Buss, et al.. (2012). Convergent Multi-miRNA Targeting of ApoE Drives LRP1/LRP8-Dependent Melanoma Metastasis and Angiogenesis. Cell. 151(5). 1068–1082. 324 indexed citations
7.
Kröger, Knut, et al.. (2001). Relevance of low titers of cryoglobulins and cold-agglutinins in patients with isolated Raynaud phenomenon.. PubMed. 24(3). 167–74. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026